TY - JOUR
T1 - Manual compression technique improves the success rate in the treatment of thrombosed aneurysmal arteriovenous fistula
T2 - A single-center experience
AU - Ko, Cheng Yu
AU - Yu, Li Ying
AU - Chen, Po Wei
AU - Ko, Chih Chang
AU - Lin, Tian Xi
AU - Lee, Cheng Han
AU - Liu, Ping Yen
AU - Chang, Hsien Yuan
N1 - Funding Information:
This work was supported by the grants from the National Cheng Kung University Hospital (NCKUH‐11105002). Funding information
Publisher Copyright:
© 2022 Wiley Periodicals LLC.
PY - 2022
Y1 - 2022
N2 - Objective: Endovascular intervention for thrombosed aneurysmal arteriovenous fistula (AVF) is still a challenge. Manual compression technique (MCT)-assisted angioplasty may be helpful, but there is no evidence or data to support it. Methods: From January 2018 to May 2021, patients with thrombosed aneurysmal AVFs were retrospectively enrolled. The patients were separated into the MCT group or the traditional group according to the procedure received. Technical failure, clinical failure, 90-day patency, and safety were analyzed. Results: A total of 159 cases (64 ± 12 years old, 60% male) were enrolled, of which 87 cases received MCT and 72 underwent traditional angioplasty. No technical failure was observed in the MCT group, while five technical failures were observed in the traditional group (0% vs. 7%, p = 0.02). There were no differences in the clinical failure rate (3% vs. 7%, p = 0.30), 90-day patency rate, or procedure time between the MCT group and the traditional group. There was no symptomatic pulmonary embolism or other complication in the two groups. Conclusion: MCT is a low-cost, less invasive, and safe procedure for thrombosed aneurysmal AVF, and it achieves a higher technical success rate than traditional angioplasty.
AB - Objective: Endovascular intervention for thrombosed aneurysmal arteriovenous fistula (AVF) is still a challenge. Manual compression technique (MCT)-assisted angioplasty may be helpful, but there is no evidence or data to support it. Methods: From January 2018 to May 2021, patients with thrombosed aneurysmal AVFs were retrospectively enrolled. The patients were separated into the MCT group or the traditional group according to the procedure received. Technical failure, clinical failure, 90-day patency, and safety were analyzed. Results: A total of 159 cases (64 ± 12 years old, 60% male) were enrolled, of which 87 cases received MCT and 72 underwent traditional angioplasty. No technical failure was observed in the MCT group, while five technical failures were observed in the traditional group (0% vs. 7%, p = 0.02). There were no differences in the clinical failure rate (3% vs. 7%, p = 0.30), 90-day patency rate, or procedure time between the MCT group and the traditional group. There was no symptomatic pulmonary embolism or other complication in the two groups. Conclusion: MCT is a low-cost, less invasive, and safe procedure for thrombosed aneurysmal AVF, and it achieves a higher technical success rate than traditional angioplasty.
UR - http://www.scopus.com/inward/record.url?scp=85140079997&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140079997&partnerID=8YFLogxK
U2 - 10.1111/sdi.13127
DO - 10.1111/sdi.13127
M3 - Article
AN - SCOPUS:85140079997
SN - 0894-0959
JO - Seminars in Dialysis
JF - Seminars in Dialysis
ER -